Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.

Andrzej S JanuszewskiHayden K YoungKwok-Leung OngLiping LiRachel L O'ConnellTimothy J LyonsClare KellyDessi P ZaharievaDavid R SullivanRussell S ScottAnthony C KeechAlicia J Jenkinsnull null

Published in: Journal of diabetes investigation (2024)

In type 2 diabetes, Hp levels differ by Hp phenotype and are decreased by fenofibrate in all phenotypes, but the effect is diminished in Hp 2-2.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
insulin resistance
metabolic syndrome